{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:50:14Z","timestamp":1790286614784,"version":"4.1.0"},"reference-count":149,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,6,30]],"date-time":"2017-06-30T00:00:00Z","timestamp":1498780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Densitometry"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.jocd.2017.06.011","type":"journal-article","created":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T23:01:51Z","timestamp":1500073311000},"page":"432-443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"title":["Fracture Risk Assessment in Patients With Diabetes Mellitus"],"prefix":"10.1016","volume":"20","author":[{"given":"Catalina","family":"Poiana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Capatina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocd.2017.06.011_bib0010","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","article-title":"An estimate of the worldwide prevalence and disability associated with osteoporotic fractures","volume":"17","author":"Johnell","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2017.06.011_bib0015","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/ageing\/aft167","article-title":"Epidemiology of lifetime fracture prevalence in England: a population study of adults aged 55 years and over","volume":"43","author":"Scholes","year":"2014","journal-title":"Age Ageing"},{"key":"10.1016\/j.jocd.2017.06.011_bib0020","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s001980170006","article-title":"Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds","volume":"12","author":"Kanis","year":"2001","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2017.06.011_bib0025","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nrendo.2016.74","article-title":"Epidemiology: the diabetes mellitus tsunami: worse than the \u201cSpanish flu\u201d pandemic?","volume":"12","author":"Yates","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jocd.2017.06.011_bib0030","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1007\/s00125-002-0858-x","article-title":"Revealing the cost of Type II diabetes in Europe","volume":"45","author":"Jonsson","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.jocd.2017.06.011_bib0035","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00198-004-1623-4","article-title":"Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden","volume":"16","author":"Kanis","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2017.06.011_bib0040","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1359\/jbmr.081207","article-title":"Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications","volume":"24","author":"Yamamoto","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.06.011_bib0045","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00264-016-3146-y","article-title":"Increased risk of vertebral fracture in patients with diabetes: a meta-analysis of cohort studies","volume":"40","author":"Wang","year":"2016","journal-title":"Int Orthop"},{"key":"10.1016\/j.jocd.2017.06.011_bib0050","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/dme.12734","article-title":"Type 1 diabetes and risk of fracture: meta-analysis and review of the literature","volume":"32","author":"Shah","year":"2015","journal-title":"Diabet Med"},{"key":"10.1016\/j.jocd.2017.06.011_bib0055","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1210\/jcem.86.1.7139","article-title":"Older women with diabetes have an increased risk of fracture: a prospective study","volume":"86","author":"Schwartz","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.06.011_bib0060","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jdiacomp.2015.05.007","article-title":"Fracture risk in patients with newly diagnosed type 2 diabetes: a retrospective database analysis in primary care","volume":"29","author":"Rathmann","year":"2015","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jocd.2017.06.011_bib0065","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.injury.2011.03.021","article-title":"Diabetes mellitus and hip fracture: a study of 5966 cases","volume":"42","author":"Norris","year":"2011","journal-title":"Injury"},{"key":"10.1016\/j.jocd.2017.06.011_bib0070","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.2337\/diacare.28.12.2850","article-title":"Elevated hip fracture risk in type 1 diabetic patients: a population-based cohort study in Sweden","volume":"28","author":"Miao","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jocd.2017.06.011_bib0075","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1464-5491.2011.03286.x","article-title":"Glycaemic control is positively associated with prevalent fractures but not with bone mineral density in patients with Type 1 diabetes","volume":"28","author":"Neumann","year":"2011","journal-title":"Diabet Med"},{"key":"10.1016\/j.jocd.2017.06.011_bib0080","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2147\/PPA.S32745","article-title":"Osteoporosis and type 2 diabetes mellitus: what do we know, and what we can do?","volume":"6","author":"Abdulameer","year":"2012","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.jocd.2017.06.011_bib0085","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1002\/jbmr.2573","article-title":"Bone geometry, volumetric density, microarchitecture, and estimated bone strength assessed by HR-pQCT in adult patients with type 1 diabetes mellitus","volume":"30","author":"Shanbhogue","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.06.011_bib0090","doi-asserted-by":"crossref","first-page":"397814","DOI":"10.1155\/2013\/397814","article-title":"A study of bone mineral density and its determinants in type 1 diabetes mellitus","volume":"2013","author":"Joshi","year":"2013","journal-title":"J Osteoporos"},{"key":"10.1016\/j.jocd.2017.06.011_bib0095","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3109\/00365513.2011.573574","article-title":"Bone density, body composition, and markers of bone remodeling in type 1 diabetic patients","volume":"71","author":"Abd El Dayem","year":"2011","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.jocd.2017.06.011_bib0100","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1002\/jbmr.1759","article-title":"Type 2 diabetes and bone","volume":"27","author":"Leslie","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.06.011_bib0105","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3138\/ptc.2010-23bh","article-title":"Bone health and type 2 diabetes mellitus: a systematic review","volume":"63","author":"Gorman","year":"2011","journal-title":"Physiother Can"},{"key":"10.1016\/j.jocd.2017.06.011_bib0110","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10654-012-9674-x","article-title":"Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies","volume":"27","author":"Ma","year":"2012","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jocd.2017.06.011_bib0115","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1472-6823-14-33","article-title":"Prevalence and determinants of osteoporosis in patients with type 1 and type 2 diabetes mellitus","volume":"14","author":"Leidig-Bruckner","year":"2014","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.jocd.2017.06.011_bib0120","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.2337\/dc12-1188","article-title":"High bone mineral density and fracture risk in type 2 diabetes as skeletal complications of inadequate glucose control: the Rotterdam Study","volume":"36","author":"Oei","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jocd.2017.06.011_bib0125","doi-asserted-by":"crossref","first-page":"102","DOI":"10.5144\/0256-4947.2008.102","article-title":"Increased bone mineral density in postmenopausal women with type 2 diabetes mellitus","volume":"28","author":"Hadzibegovic","year":"2008","journal-title":"Ann Saudi Med"},{"key":"10.1016\/j.jocd.2017.06.011_bib0130","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00198-004-1786-z","article-title":"Decreased bone mineral density at the distal radius, but not at the lumbar spine or the femoral neck, in Japanese type 2 diabetic patients","volume":"16","author":"Majima","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2017.06.011_bib0135","first-page":"4","article-title":"Bone density assessment and type 2 diabetes mellitus in postmenopausal women","volume":"22","author":"Carsote","year":"2013","journal-title":"Romanian J Rheumathol"},{"key":"10.1016\/j.jocd.2017.06.011_bib0140","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1210\/jc.2010-0226","article-title":"High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus","volume":"95","author":"Burghardt","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.06.011_bib0145","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s00592-005-0183-1","article-title":"Influence of diabetes on peripheral bone mineral density in men: a controlled study","volume":"42","author":"Bridges","year":"2005","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.jocd.2017.06.011_bib0150","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","article-title":"Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes\u2014a meta-analysis","volume":"18","author":"Vestergaard","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2017.06.011_bib0155","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1210\/jc.2006-0614","article-title":"Risk of fracture in women with type 2 diabetes: the Women's Health Initiative Observational Study","volume":"91","author":"Bonds","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.06.011_bib0160","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/archinte.165.14.1612","article-title":"Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study","volume":"165","author":"Strotmeyer","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jocd.2017.06.011_bib0165","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1007\/s00125-005-1786-3","article-title":"Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk","volume":"48","author":"Vestergaard","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.jocd.2017.06.011_bib0170","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/aje\/kwm106","article-title":"Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture","volume":"166","author":"Janghorbani","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jocd.2017.06.011_bib0175","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s40520-016-0562-1","article-title":"Type 2 diabetes and risk of low-energy fractures in postmenopausal women: meta-analysis of observational studies","volume":"29","author":"Dytfeld","year":"2017","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.jocd.2017.06.011_bib0180","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.2337\/dc12-1355","article-title":"Prevalence of morphometric vertebral fractures in patients with type 1 diabetes","volume":"36","author":"Zhukouskaya","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jocd.2017.06.011_bib0185","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00198-005-0013-x","article-title":"Diabetes mellitus and the risk of non-vertebral fractures: the Tromso study","volume":"17","author":"Ahmed","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2017.06.011_bib0190","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s00125-014-3289-6","article-title":"Fracture risk in diabetic elderly men: the MrOS study","volume":"57","author":"Napoli","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.jocd.2017.06.011_bib0195","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s00198-005-1909-1","article-title":"Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study","volume":"16","author":"de Liefde","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2017.06.011_bib0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067055","article-title":"Understanding the relationship between type 2 diabetes mellitus and falls in older adults: a prospective cohort study","volume":"8","author":"Roman de Mettelinge","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jocd.2017.06.011_bib0205","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jdiacomp.2005.06.004","article-title":"Falls as a complication of diabetes mellitus in older people","volume":"20","author":"Tilling","year":"2006","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jocd.2017.06.011_bib0210","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00223-007-9082-5","article-title":"Risk factors for fractures and falls in older women with type 2 diabetes mellitus","volume":"82","author":"Patel","year":"2008","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jocd.2017.06.011_bib0215","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/ageing\/afr145","article-title":"Older individuals with diabetes have an increased risk of recurrent falls: analysis of potential mediating factors: the Longitudinal Ageing Study Amsterdam","volume":"41","author":"Pijpers","year":"2012","journal-title":"Age Ageing"},{"key":"10.1016\/j.jocd.2017.06.011_bib0220","doi-asserted-by":"crossref","first-page":"e627","DOI":"10.1542\/peds.2005-2193","article-title":"Early manifestation of type 1 diabetes in children is a risk factor for changed bone geometry: data using peripheral quantitative computed tomography","volume":"118","author":"Bechtold","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.jocd.2017.06.011_bib0225","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00198-008-0810-0","article-title":"Bone mass and structure in adolescents with type 1 diabetes compared to healthy peers","volume":"20","author":"Saha","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2017.06.011_bib0230","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.2337\/dc07-0142","article-title":"Bone size normalizes with age in children and adolescents with type 1 diabetes","volume":"30","author":"Bechtold","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jocd.2017.06.011_bib0235","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bone.2011.09.055","article-title":"Trabecular bone histomorphometry in humans with type 1 diabetes mellitus","volume":"50","author":"Armas","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.jocd.2017.06.011_bib0240","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/jbmr.2106","article-title":"In vivo assessment of bone quality in postmenopausal women with type 2 diabetes","volume":"29","author":"Farr","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.06.011_bib0245","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00198-011-1595-0","article-title":"Bone structure and turnover in type 2 diabetes mellitus","volume":"23","author":"Shu","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2017.06.011_bib0250","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00223-015-0100-8","article-title":"Bone microarchitecture in men and women with diabetes: the importance of cortical porosity","volume":"98","author":"Paccou","year":"2016","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jocd.2017.06.011_bib0255","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1210\/jc.2016-1437","article-title":"Advanced glycation endproducts and bone material strength in type 2 diabetes","volume":"101","author":"Furst","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.06.011_bib0260","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1590\/0004-2730000003456","article-title":"Trabecular bone score: perspectives of an imaging technology coming of age","volume":"58","author":"Silva","year":"2014","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.jocd.2017.06.011_bib0265","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00198-015-3222-y","article-title":"Trabecular bone score in type 1 diabetes\u2014a cross-sectional study","volume":"27","author":"Neumann","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2017.06.011_bib0270","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s00198-014-2704-7","article-title":"Bone quality assessment in type 2 diabetes mellitus","volume":"25","author":"Dhaliwal","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2017.06.011_bib0275","doi-asserted-by":"crossref","first-page":"E735","DOI":"10.1152\/ajpendo.00159.2005","article-title":"Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues","volume":"289","author":"Thrailkill","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.06.011_bib0280","first-page":"1194","article-title":"Influence of age, sex, and insulin on osteoblast function: osteoblast dysfunction in diabetes mellitus","volume":"80","author":"Bouillon","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.06.011_bib0285","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF03343726","article-title":"Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology","volume":"23","author":"Kemink","year":"2000","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.jocd.2017.06.011_bib0290","first-page":"26","article-title":"Relationship between insulin-like growth factor 1 and leptin in type II diabetic patients","volume":"1","author":"Zarghami","year":"2009","journal-title":"Int J Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.06.011_bib0295","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ghir.2007.01.007","article-title":"Association of serum levels of IGF-I and IGFBP-1 with renal function in patients with type 2 diabetes mellitus","volume":"17","author":"Akturk","year":"2007","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.jocd.2017.06.011_bib0300","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bone.2013.06.029","article-title":"Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes","volume":"56","author":"Ardawi","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.jocd.2017.06.011_bib0305","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.amjmed.2011.06.013","article-title":"Obesity is not protective against fracture in postmenopausal women: GLOW","volume":"124","author":"Compston","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.jocd.2017.06.011_bib0310","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/jbmr.1466","article-title":"The association between fracture and obesity is site-dependent: a population-based study in postmenopausal women","volume":"27","author":"Prieto-Alhambra","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.06.011_bib0315","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph13060544","article-title":"BMI and BMD: the potential interplay between obesity and bone fragility","volume":"13","author":"Palermo","year":"2016","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jocd.2017.06.011_bib0320","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/jbmr.1950","article-title":"Bone marrow fat composition as a novel imaging biomarker in postmenopausal women with prevalent fragility fractures","volume":"28","author":"Patsch","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.06.011_bib0325","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cyto.2016.01.011","article-title":"TNF-alpha is upregulated in T2DM patients with fracture and promotes the apoptosis of osteoblast cells in vitro in the presence of high glucose","volume":"80","author":"Sun","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.jocd.2017.06.011_bib0330","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/jbmr.2462","article-title":"Glycated hemoglobin level and risk of hip fracture in older people with type 2 diabetes: a competing risk analysis of Taiwan diabetes cohort study","volume":"30","author":"Li","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.06.011_bib0335","first-page":"1665","article-title":"[Bone quality]","volume":"73","author":"Saito","year":"2015","journal-title":"Nihon Rinsho"},{"key":"10.1016\/j.jocd.2017.06.011_bib0340","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.metabol.2014.09.002","article-title":"Type 2 diabetes mellitus and fracture risk","volume":"63","author":"Dede","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.jocd.2017.06.011_bib0345","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.acthis.2013.01.004","article-title":"Morphological changes induced by advanced glycation endproducts in osteoblastic cells: effects of co-incubation with alendronate","volume":"115","author":"Gangoiti","year":"2013","journal-title":"Acta Histochem"},{"key":"10.1016\/j.jocd.2017.06.011_bib0350","doi-asserted-by":"crossref","first-page":"E355","DOI":"10.1152\/ajpendo.00309.2015","article-title":"Advanced glycation end products biphasically modulate bone resorption in osteoclast-like cells","volume":"310","author":"Li","year":"2016","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.06.011_bib0355","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1210\/jc.2007-1270","article-title":"Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes","volume":"93","author":"Yamamoto","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.06.011_bib0360","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1507\/endocrj.42.377","article-title":"Effect of glycemic control on calcium and phosphorus handling and parathyroid hormone level in patients with non-insulin-dependent diabetes mellitus","volume":"42","author":"Nagasaka","year":"1995","journal-title":"Endocr J"},{"key":"10.1016\/j.jocd.2017.06.011_bib0365","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00592-011-0347-0","article-title":"Serum levels of bone resorption markers are decreased in patients with type 2 diabetes","volume":"50","author":"Reyes-Garcia","year":"2013","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.jocd.2017.06.011_bib0370","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1530\/EJE-15-0860","article-title":"Compromised cortical bone compartment in type 2 diabetes mellitus patients with microvascular disease","volume":"174","author":"Shanbhogue","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jocd.2017.06.011_bib0375","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s40618-014-0092-7","article-title":"Osteocalcin levels are inversely associated with Hba1c and BMI in adult subjects with long-standing type 1 diabetes","volume":"37","author":"Maddaloni","year":"2014","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.jocd.2017.06.011_bib0380","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1515\/JPEM.2010.23.1-2.81","article-title":"Biochemical markers of bone cell activity in children with type 1 diabetes mellitus","volume":"23","author":"Pater","year":"2010","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.06.011_bib0385","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1365-2265.1998.00374.x","article-title":"Urinary glycosylated, free and total pyridinoline and free and total deoxypyridinoline in diabetes mellitus","volume":"48","author":"Cloos","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jocd.2017.06.011_bib0390","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bone.2015.11.004","article-title":"Differences in biochemical bone markers by diabetes type and the impact of glucose","volume":"83","author":"Starup-Linde","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.jocd.2017.06.011_bib0395","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s00198-014-2988-7","article-title":"Volumetric femoral BMD, bone geometry, and serum sclerostin levels differ between type 2 diabetic postmenopausal women with and without fragility fractures","volume":"26","author":"Heilmeier","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2017.06.011_bib0400","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1210\/jc.2011-2186","article-title":"Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus","volume":"97","author":"Garcia-Martin","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.06.011_bib0405","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/cen.12364","article-title":"Clinical and endocrine correlates of circulating sclerostin levels in patients with type 1 diabetes mellitus","volume":"80","author":"Neumann","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jocd.2017.06.011_bib0410","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1530\/EJE-14-0106","article-title":"Gender differences in sclerostin and clinical characteristics in type 1 diabetes mellitus","volume":"171","author":"Catalano","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jocd.2017.06.011_bib0415","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1001-9294(13)60038-3","article-title":"Role of sclerostin in the bone loss of postmenopausal Chinese women with type 2 diabetes","volume":"28","author":"Zhou","year":"2013","journal-title":"Chin Med Sci J"},{"key":"10.1016\/j.jocd.2017.06.011_bib0420","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s00198-015-3422-5","article-title":"Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis","volume":"27","author":"Tsentidis","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2017.06.011_bib0425","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1515\/JPEM.2010.23.7.697","article-title":"Decreased bone turnover in children and adolescents with well controlled type 1 diabetes","volume":"23","author":"Maggio","year":"2010","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.06.011_bib0430","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/07315724.1986.10720112","article-title":"Serum alkaline phosphatase in diabetes mellitus","volume":"5","author":"Maxwell","year":"1986","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.jocd.2017.06.011_bib0435","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fendo.2013.00021","article-title":"Diabetes, biochemical markers of bone turnover, diabetes control, and bone","volume":"4","author":"Starup-Linde","year":"2013","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jocd.2017.06.011_bib0440","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/pedi.12288","article-title":"Sclerostin distribution in children and adolescents with type 1 diabetes mellitus and correlation with bone metabolism and bone mineral density","volume":"17","author":"Tsentidis","year":"2016","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jocd.2017.06.011_bib0445","first-page":"16","article-title":"Serum osteoprotegerin: bone or cardiovascular marker in Type 2 diabetes males?","volume":"36","author":"Rozas Moreno","year":"2013","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.jocd.2017.06.011_bib0450","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1210\/jc.2011-2537","article-title":"Decreased PTH levels accompanied by low bone formation are associated with vertebral fractures in postmenopausal women with type 2 diabetes","volume":"97","author":"Yamamoto","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.06.011_bib0455","first-page":"1718","article-title":"[Diabetes-related osteoporosis]","volume":"73","author":"Kanazawa","year":"2015","journal-title":"Nihon Rinsho"},{"key":"10.1016\/j.jocd.2017.06.011_bib0460","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jocd.2011.06.007","article-title":"Clinical risk factors for fracture in diabetes: a matched cohort analysis","volume":"14","author":"Fraser","year":"2011","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jocd.2017.06.011_bib0465","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.2337\/diacare.24.7.1198","article-title":"Diabetes and risk of fracture: the Blue Mountains Eye Study","volume":"24","author":"Ivers","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jocd.2017.06.011_bib0470","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1359\/jbmr.080323","article-title":"Fracture risk in type 2 diabetes: update of a population-based study","volume":"23","author":"Melton","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.06.011_bib0475","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00223-008-9195-5","article-title":"Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes","volume":"84","author":"Vestergaard","year":"2009","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jocd.2017.06.011_bib0480","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/jbmr.235","article-title":"BMI and fracture risk in older men: the Osteoporotic Fractures in Men Study (MrOS)","volume":"26","author":"Nielson","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.06.011_bib0485","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00198-012-2209-1","article-title":"Overweight\/obesity and underweight are both risk factors for osteoporotic fractures at different sites in Japanese postmenopausal women","volume":"24","author":"Tanaka","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2017.06.011_bib0490","doi-asserted-by":"crossref","first-page":"5","DOI":"10.14712\/23362936.2016.1","article-title":"High prevalence of hypovitaminosis D in postmenopausal women with type 2 diabetes mellitus","volume":"117","author":"Raska","year":"2016","journal-title":"Prague Med Rep"},{"key":"10.1016\/j.jocd.2017.06.011_bib0495","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1056\/NEJMoa1109617","article-title":"A pooled analysis of vitamin D dose requirements for fracture prevention","volume":"367","author":"Bischoff-Ferrari","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocd.2017.06.011_bib0500","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1210\/jc.2014-2136","article-title":"Clinical review: effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis","volume":"99","author":"Seida","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.06.011_bib0505","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2337\/dc07-1829","article-title":"Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative","volume":"31","author":"de Boer","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jocd.2017.06.011_bib0510","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/jbmr.556","article-title":"FRAX underestimates fracture risk in patients with diabetes","volume":"27","author":"Giangregorio","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.06.011_bib0515","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1001\/jama.2011.715","article-title":"Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes","volume":"305","author":"Schwartz","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jocd.2017.06.011_bib0520","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1007\/s00198-014-2822-2","article-title":"Does diabetes modify the effect of FRAX risk factors for predicting major osteoporotic and hip fracture?","volume":"25","author":"Leslie","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2017.06.011_bib0525","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bone.2014.12.008","article-title":"Diabetes and fracture risk in older U.S. adults","volume":"82","author":"Looker","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.jocd.2017.06.011_bib0530","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1359\/jbmr.1999.14.5.821","article-title":"Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group","volume":"14","author":"Black","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.06.011_bib0535","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jocd.2016.04.001","article-title":"Trabecular bone score (TBS) and TBS-adjusted fracture risk assessment tool are potential supplementary tools for the discrimination of morphometric vertebral fractures in postmenopausal women with type 2 diabetes","volume":"19","author":"Choi","year":"2016","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jocd.2017.06.011_bib0540","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1210\/jc.2012-3118","article-title":"TBS (trabecular bone score) and diabetes-related fracture risk","volume":"98","author":"Leslie","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.06.011_bib0545","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/jbmr.2734","article-title":"A meta-analysis of trabecular bone score in fracture risk prediction and its relationship to FRAX","volume":"31","author":"McCloskey","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.06.011_bib0550","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s00223-016-0191-x","article-title":"DXA-based measurements in diabetes: can they predict fracture risk?","volume":"100","author":"Schacter","year":"2017","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jocd.2017.06.011_bib0555","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1210\/jc.2008-2498","article-title":"Pentosidine and increased fracture risk in older adults with type 2 diabetes","volume":"94","author":"Schwartz","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.06.011_bib0560","first-page":"11","article-title":"Risk of fracture with thiazolidinediones: an individual patient data meta-analysis","volume":"4","author":"Bazelier","year":"2013","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jocd.2017.06.011_bib0565","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s00223-012-9591-8","article-title":"Risk of fracture with thiazolidinediones: disease or drugs?","volume":"90","author":"Bazelier","year":"2012","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jocd.2017.06.011_bib0570","doi-asserted-by":"crossref","first-page":"602","DOI":"10.7326\/0003-4819-154-9-201105030-00336","article-title":"Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations","volume":"154","author":"Bennett","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jocd.2017.06.011_bib0575","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/cbf.3025","article-title":"PPAR agonists stimulate adipogenesis at the expense of osteoblast differentiation while inhibiting osteoclast formation and activity","volume":"32","author":"Patel","year":"2014","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/j.jocd.2017.06.011_bib0580","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1210\/jc.2012-4018","article-title":"Rosiglitazone decreases bone mineral density and increases bone turnover in postmenopausal women with type 2 diabetes mellitus","volume":"98","author":"Bilezikian","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.06.011_bib0585","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1007\/s00125-015-3660-2","article-title":"The effect of thiazolidinediones on bone mineral density and bone turnover: systematic review and meta-analysis","volume":"58","author":"Billington","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.jocd.2017.06.011_bib0590","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1210\/jc.2009-1385","article-title":"Thiazolidinedione use and the longitudinal risk of fractures in patients with type 2 diabetes mellitus","volume":"95","author":"Habib","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.06.011_bib0595","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s00774-010-0160-9","article-title":"Relationship between treatments with insulin and oral hypoglycemic agents versus the presence of vertebral fractures in type 2 diabetes mellitus","volume":"28","author":"Kanazawa","year":"2010","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.jocd.2017.06.011_bib0600","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejphar.2006.02.030","article-title":"Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture","volume":"536","author":"Cortizo","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jocd.2017.06.011_bib0605","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0377-1237(11)60120-2","article-title":"Evaluation of bone mineral density in type 2 diabetes mellitus patients before and after treatment","volume":"68","author":"Dutta","year":"2012","journal-title":"Med J Armed Forces India"},{"key":"10.1016\/j.jocd.2017.06.011_bib0610","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa066224","article-title":"Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy","volume":"355","author":"Kahn","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocd.2017.06.011_bib0615","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2337\/dc07-1736","article-title":"Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case-control study","volume":"31","author":"Monami","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jocd.2017.06.011_bib0620","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4239\/wjd.v7.i6.122","article-title":"Metformin revisited: does this regulator of AMP-activated protein kinase secondarily affect bone metabolism and prevent diabetic osteopathy","volume":"7","author":"McCarthy","year":"2016","journal-title":"World J Diabetes"},{"key":"10.1016\/j.jocd.2017.06.011_bib0625","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s40266-015-0254-0","article-title":"Sulfonylurea use and risk of hip fractures among elderly men and women with type 2 diabetes","volume":"32","author":"Rajpathak","year":"2015","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jocd.2017.06.011_bib0630","first-page":"117","article-title":"Hypoglycemia: a major problem in the management of diabetes in the elderly","volume":"5","author":"Stepka","year":"1993","journal-title":"Aging (Milano)"},{"key":"10.1016\/j.jocd.2017.06.011_bib0635","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1345\/aph.1M551","article-title":"Diabetes medications related to an increased risk of falls and fall-related morbidity in the elderly","volume":"44","author":"Berlie","year":"2010","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jocd.2017.06.011_bib0640","first-page":"17","article-title":"Fracture risk in patients with type 2 diabetes under different antidiabetic treatment regimens: a retrospective database analysis in primary care","volume":"9","author":"Pscherer","year":"2016","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.jocd.2017.06.011_bib0645","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/dom.12786","article-title":"Sitagliptin and risk of fractures in type 2 diabetes: results from the TECOS trial","volume":"19","author":"Josse","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jocd.2017.06.011_bib0650","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s001980070114","article-title":"Intensive insulin therapy and bone mineral density in type 1 diabetes mellitus: a prospective study","volume":"11","author":"Campos Pastor","year":"2000","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2017.06.011_bib0655","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1210\/jc.2015-1860","article-title":"Evaluation of bone mineral density and bone biomarkers in patients with type 2 diabetes treated with canagliflozin","volume":"101","author":"Bilezikian","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.06.011_bib0660","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1210\/jc.2015-3167","article-title":"Effects of canagliflozin on fracture risk in patients with type 2 diabetes mellitus","volume":"101","author":"Watts","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.06.011_bib0665","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/dom.12742","article-title":"Lack of evidence for a harmful effect of sodium-glucose cotransporter 2 (SGLT2) inhibitors on fracture risk among type 2 diabetes patients: a network and cumulative meta-analysis of randomized controlled trials","volume":"18","author":"Tang","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jocd.2017.06.011_bib0670","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.bone.2015.08.006","article-title":"Chronic administration of Glucagon-like peptide-1 receptor agonists improves trabecular bone mass and architecture in ovariectomised mice","volume":"81","author":"Pereira","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.jocd.2017.06.011_bib0675","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.2337\/dc11-1099","article-title":"Dipeptidyl peptidase-4 inhibitors and bone fractures: a meta-analysis of randomized clinical trials","volume":"34","author":"Monami","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jocd.2017.06.011_bib0680","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s00223-015-0037-y","article-title":"Use of glucagon-like-peptide 1 receptor agonists and risk of fracture as compared to use of other anti-hyperglycemic drugs","volume":"97","author":"Driessen","year":"2015","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jocd.2017.06.011_bib0685","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.2337\/dc11-2184","article-title":"Intensive glycemic control is not associated with fractures or falls in the ACCORD randomized trial","volume":"35","author":"Schwartz","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jocd.2017.06.011_bib0690","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.diabres.2015.05.009","article-title":"Sulfonylureas and risk of falls and fractures among nursing home residents with type 2 diabetes mellitus","volume":"109","author":"Lapane","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jocd.2017.06.011_bib0695","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00223-015-9993-5","article-title":"Bone fracture risk is not associated with the use of glucagon-like peptide-1 receptor agonists: a population-based cohort analysis","volume":"97","author":"Driessen","year":"2015","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jocd.2017.06.011_bib0700","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bone.2014.07.030","article-title":"Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture","volume":"68","author":"Driessen","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.jocd.2017.06.011_bib0705","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/MED.0b013e328325d155","article-title":"Bone metabolism in type 2 diabetes and role of thiazolidinediones","volume":"16","author":"Vestergaard","year":"2009","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.jocd.2017.06.011_bib0710","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2174\/1566524023362104","article-title":"Bisphosphonate mechanism of action","volume":"2","author":"Rodan","year":"2002","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.jocd.2017.06.011_bib0715","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2337\/diacare.27.7.1547","article-title":"Effect of alendronate on bone mineral density and biochemical markers of bone turnover in type 2 diabetic women: the fracture intervention trial","volume":"27","author":"Keegan","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jocd.2017.06.011_bib0720","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.diabres.2011.03.033","article-title":"Three-year experience with alendronate treatment in postmenopausal osteoporotic Japanese women with or without type 2 diabetes","volume":"93","author":"Iwamoto","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jocd.2017.06.011_bib0725","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0149-2918(03)80114-5","article-title":"Post hoc analysis of data from the Multiple Outcomes of Raloxifene Evaluation (MORE) trial on the effects of three years of raloxifene treatment on glycemic control and cardiovascular disease risk factors in women with and without type 2 diabetes","volume":"25","author":"Barrett-Connor","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.jocd.2017.06.011_bib0730","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bone.2016.06.017","article-title":"Teriparatide in patients with osteoporosis and type 2 diabetes","volume":"91","author":"Schwartz","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.jocd.2017.06.011_bib0735","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4103\/2230-8210.146871","article-title":"A randomized placebo-controlled trial of the efficacy of denosumab in Indian postmenopausal women with osteoporosis","volume":"19","author":"Pitale","year":"2015","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.06.011_bib0740","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00223-010-9450-4","article-title":"Are antiresorptive drugs effective against fractures in patients with diabetes?","volume":"88","author":"Vestergaard","year":"2011","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jocd.2017.06.011_bib0745","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s10654-015-0058-x","article-title":"Association of serum total osteocalcin with type 2 diabetes and intermediate metabolic phenotypes: systematic review and meta-analysis of observational evidence","volume":"30","author":"Kunutsor","year":"2015","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jocd.2017.06.011_bib0750","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/jbmr.1865","article-title":"Effects of antiresorptive therapies on glucose metabolism: results from the FIT, HORIZON-PFT, and FREEDOM trials","volume":"28","author":"Schwartz","year":"2013","journal-title":"J Bone Miner Res"}],"container-title":["Journal of Clinical Densitometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109469501730104X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109469501730104X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:41:39Z","timestamp":1761082899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109469501730104X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":149,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S109469501730104X"],"URL":"https:\/\/doi.org\/10.1016\/j.jocd.2017.06.011","relation":{},"ISSN":["1094-6950"],"issn-type":[{"value":"1094-6950","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fracture Risk Assessment in Patients With Diabetes Mellitus","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Densitometry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocd.2017.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors.","name":"copyright","label":"Copyright"}]}}